Press release |

Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline.

Read more
Photography by Atul Loke

Latest news

What good is a breakthrough medicine if the people who need it can't afford it?